<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Oral Cancer News &#187; human papilloma virus</title>
	<atom:link href="http://oralcancernews.org/wp/tag/human-papilloma-virus/feed/" rel="self" type="application/rss+xml" />
	<link>http://oralcancernews.org/wp</link>
	<description>The Oral Cancer Foundation News Archive</description>
	<lastBuildDate>Tue, 27 Jul 2010 19:28:38 +0000</lastBuildDate>
	<generator>http://wordpress.org/?v=2.9.2</generator>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
			<item>
		<title>Dispatch: get vaccinated!</title>
		<link>http://oralcancernews.org/wp/dispatch-get-vaccinated/</link>
		<comments>http://oralcancernews.org/wp/dispatch-get-vaccinated/#comments</comments>
		<pubDate>Fri, 23 Jul 2010 21:55:06 +0000</pubDate>
		<dc:creator>Oral Cancer Foundation News Team</dc:creator>
				<category><![CDATA[Oral Cancer News]]></category>
		<category><![CDATA[cervical cancer]]></category>
		<category><![CDATA[GlaxoSmithKline]]></category>
		<category><![CDATA[HPV]]></category>
		<category><![CDATA[human papilloma virus]]></category>
		<category><![CDATA[Merck]]></category>
		<category><![CDATA[throat cancer]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=9164</guid>
		<description><![CDATA[
			
				
			
		
Source: American Council on Science and Health
Author: Staff
According to U.S. researchers, there are an estimated 11,300 throat cancer cases attributable to human papilloma virus (HPV) annually, although the government does not formally track the incidence rate since the connection between HPV and throat cancer was only made in the past few years. The rate is [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/dispatch-get-vaccinated/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>New oral cancer data could prompt new treatments</title>
		<link>http://oralcancernews.org/wp/new-oral-cancer-data-could-prompt-new-treatments/</link>
		<comments>http://oralcancernews.org/wp/new-oral-cancer-data-could-prompt-new-treatments/#comments</comments>
		<pubDate>Wed, 09 Jun 2010 17:00:14 +0000</pubDate>
		<dc:creator>Oral Cancer Foundation News Team</dc:creator>
				<category><![CDATA[OCF In The News]]></category>
		<category><![CDATA[Oral Cancer News]]></category>
		<category><![CDATA[American Society of Clinical Oncolog]]></category>
		<category><![CDATA[Dr. Maura Gillison]]></category>
		<category><![CDATA[head and neck cancer]]></category>
		<category><![CDATA[HPV]]></category>
		<category><![CDATA[human papilloma virus]]></category>
		<category><![CDATA[New England Journal of Medicine]]></category>
		<category><![CDATA[Ohio State University]]></category>
		<category><![CDATA[oral cancer]]></category>
		<category><![CDATA[oral cancer foundation]]></category>
		<category><![CDATA[radiation]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=8840</guid>
		<description><![CDATA[
			
				
			
		
Source: The Columbus Disbatch
Author: Misti Crane
Doctors are focusing increasingly on the role that human papilloma virus plays in oral cancer, and new research is prompting hope that treatments can be better tailored to patients.
People with oral cancer have a better chance of surviving if the cancer is linked to HPV, according to a new study [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/new-oral-cancer-data-could-prompt-new-treatments/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Sexually transmitted virus leads to rise in oral cancer</title>
		<link>http://oralcancernews.org/wp/sexually-transmitted-virus-leads-to-rise-in-oral-cancer/</link>
		<comments>http://oralcancernews.org/wp/sexually-transmitted-virus-leads-to-rise-in-oral-cancer/#comments</comments>
		<pubDate>Fri, 14 May 2010 19:37:14 +0000</pubDate>
		<dc:creator>Oral Cancer Foundation News Team</dc:creator>
				<category><![CDATA[Oral Cancer News]]></category>
		<category><![CDATA[Cervarix]]></category>
		<category><![CDATA[Dana Farber Cancer Institute]]></category>
		<category><![CDATA[FDA]]></category>
		<category><![CDATA[Gardasil]]></category>
		<category><![CDATA[HPV]]></category>
		<category><![CDATA[human papilloma virus]]></category>
		<category><![CDATA[oral cancer]]></category>
		<category><![CDATA[oropharyngeal cancer]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=8616</guid>
		<description><![CDATA[
			
				
			
		
Source: The Boston Channel
Author: Staff
Boston cancer specialists are trying to learn what’s behind an “epidemic” spike in oral cancer cases that they say is caused by the human papillomavirus, commonly known as HPV.
“What you&#8217;re seeing here is a five-fold increase in the numbers that we would expect,” said Dr. Marshall R. Posner, of the Dana [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/sexually-transmitted-virus-leads-to-rise-in-oral-cancer/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>HPV types 16/18 adjuvant vaccine shows long-term efficacy</title>
		<link>http://oralcancernews.org/wp/hpv-types-1618-adjuvant-vaccine-shows-long-term-efficacy/</link>
		<comments>http://oralcancernews.org/wp/hpv-types-1618-adjuvant-vaccine-shows-long-term-efficacy/#comments</comments>
		<pubDate>Wed, 12 May 2010 17:34:29 +0000</pubDate>
		<dc:creator>Oral Cancer Foundation News Team</dc:creator>
				<category><![CDATA[Oral Cancer News]]></category>
		<category><![CDATA[GlaxoSmithKline]]></category>
		<category><![CDATA[HPV]]></category>
		<category><![CDATA[HPV 16 & 18]]></category>
		<category><![CDATA[hpv vaccine]]></category>
		<category><![CDATA[human papilloma virus]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=8605</guid>
		<description><![CDATA[
			
				
			
		
Source: DocGuide.com
Author: Jenny Powers
NICE, France &#8212; May 11, 2010 &#8212; The human papillomavirus (HPV) vaccine (types 16 and 18) AS04-adjuvanted vaccine shows a sustained immune response, as demonstrated by high levels of neutralising antibodies, up to 8.4 years after first vaccination, researchers said here at the 28th Annual Meeting of the European Society for Paediatric [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/hpv-types-1618-adjuvant-vaccine-shows-long-term-efficacy/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>HPV-Positive head and neck cancer: favorable prognosis does not lead to clear choices for changes in treatments</title>
		<link>http://oralcancernews.org/wp/hpv-positive-head-and-neck-cancer-favorable-prognosis-does-not-lead-to-clear-choices/</link>
		<comments>http://oralcancernews.org/wp/hpv-positive-head-and-neck-cancer-favorable-prognosis-does-not-lead-to-clear-choices/#comments</comments>
		<pubDate>Thu, 15 Apr 2010 18:52:32 +0000</pubDate>
		<dc:creator>Oral Cancer Foundation News Team</dc:creator>
				<category><![CDATA[Oral Cancer News]]></category>
		<category><![CDATA[Dr. Maura Gillison]]></category>
		<category><![CDATA[head and neck cancer]]></category>
		<category><![CDATA[HPV]]></category>
		<category><![CDATA[human papilloma virus]]></category>
		<category><![CDATA[Ohio State Universoty]]></category>
		<category><![CDATA[radiation oncology]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=8328</guid>
		<description><![CDATA[
			
				
			
		
Source: OncologyStat
Author: Thomas F. Pajak
CHANDLER, Ariz. (EGMN) &#8211; Human papillomavirus infection is clearly a prognostic factor in patients with head and neck cancer. But whether HPV status can be used to guide treatment decisions is far from clear, according to speakers at a head and neck cancer symposium sponsored by the American Society for Radiation [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/hpv-positive-head-and-neck-cancer-favorable-prognosis-does-not-lead-to-clear-choices/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Expand+Bcl2 and human papilloma virus 16 as predictors of outcome following concurrent chemoradiation for advanced oropharyngeal cancer</title>
		<link>http://oralcancernews.org/wp/expandbcl2-and-human-papilloma-virus-16-as-predictors-of-outcome-following-concurrent-chemoradiation-for-advanced-oropharyngeal-cancer/</link>
		<comments>http://oralcancernews.org/wp/expandbcl2-and-human-papilloma-virus-16-as-predictors-of-outcome-following-concurrent-chemoradiation-for-advanced-oropharyngeal-cancer/#comments</comments>
		<pubDate>Sun, 04 Apr 2010 15:52:04 +0000</pubDate>
		<dc:creator>Oral Cancer Foundation News Team</dc:creator>
				<category><![CDATA[Oral Cancer News]]></category>
		<category><![CDATA[antiapoptotic protein]]></category>
		<category><![CDATA[Bcl2]]></category>
		<category><![CDATA[chemoradiation]]></category>
		<category><![CDATA[concurrent chemoradiation]]></category>
		<category><![CDATA[HPV]]></category>
		<category><![CDATA[human papilloma virus]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=8257</guid>
		<description><![CDATA[
			
				
			
		
Source: Clin Cancer Res; 16(7); 2138–46
Authors:  Anthony C. Nichols et al.
Purpose:
Oropharyngeal squamous cell carcinoma (OPSCC) associated with human papilloma virus (HPV) is rapidly growing in incidence. Despite better prognosis than OPSCC associated with traditional risk factors, treatment failure still occurs in a significant proportion of patients. We had identified the antiapoptotic protein Bcl2 as [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/expandbcl2-and-human-papilloma-virus-16-as-predictors-of-outcome-following-concurrent-chemoradiation-for-advanced-oropharyngeal-cancer/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Rise in mouth cancer linked to STI&#8217;s, primarily HPV16</title>
		<link>http://oralcancernews.org/wp/rise-in-mouth-cancer-linked-to-stis/</link>
		<comments>http://oralcancernews.org/wp/rise-in-mouth-cancer-linked-to-stis/#comments</comments>
		<pubDate>Tue, 30 Mar 2010 03:28:12 +0000</pubDate>
		<dc:creator>Oral Cancer Foundation News Team</dc:creator>
				<category><![CDATA[Oral Cancer News]]></category>
		<category><![CDATA[biopsies]]></category>
		<category><![CDATA[HPV]]></category>
		<category><![CDATA[human papilloma virus]]></category>
		<category><![CDATA[oral sex]]></category>
		<category><![CDATA[oropharyngeal carcinoma]]></category>
		<category><![CDATA[prognosis]]></category>
		<category><![CDATA[vaccination]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=8221</guid>
		<description><![CDATA[
			
				
			
		
Source: www.nhs.uk
Author: staff
The Daily Telegraph reported that a “rise in mouth cancer may be due to sexually transmitted infection”. The newspaper said that there has been a 50% increase in the number of mouth cancers in the last 20 years, and the increase appears to be in those cases related to the human papilloma virus [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/rise-in-mouth-cancer-linked-to-stis/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Oropharyngeal carcinoma related to human papillomavirus</title>
		<link>http://oralcancernews.org/wp/oropharyngeal-carcinoma-related-to-human-papillomavirus/</link>
		<comments>http://oralcancernews.org/wp/oropharyngeal-carcinoma-related-to-human-papillomavirus/#comments</comments>
		<pubDate>Fri, 26 Mar 2010 23:16:09 +0000</pubDate>
		<dc:creator>Oral Cancer Foundation News Team</dc:creator>
				<category><![CDATA[Oral Cancer News]]></category>
		<category><![CDATA[HPV]]></category>
		<category><![CDATA[human papilloma virus]]></category>
		<category><![CDATA[oropharyngeal squamous cell carcinomas]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=8213</guid>
		<description><![CDATA[
			
				
			
		
Source: BMJ 2010;340:c1439
Author: Staff
Incidence is increasing rapidly, with implications for prognosis and policy
Head and neck cancer is the sixth most common cancer, with about 640,000 new cases each year worldwide. Despite an overall marginal decline in the incidence of most head and neck cancers in recent years,1 the incidence of oropharyngeal squamous cell carcinoma has increased greatly, especially in the [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/oropharyngeal-carcinoma-related-to-human-papillomavirus/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>HPV-related cancer not confined to cervix</title>
		<link>http://oralcancernews.org/wp/hpv-related-cancer-not-confined-to-cervix/</link>
		<comments>http://oralcancernews.org/wp/hpv-related-cancer-not-confined-to-cervix/#comments</comments>
		<pubDate>Fri, 12 Mar 2010 02:12:43 +0000</pubDate>
		<dc:creator>Oral Cancer Foundation News Team</dc:creator>
				<category><![CDATA[Oral Cancer News]]></category>
		<category><![CDATA[alcohol]]></category>
		<category><![CDATA[anal cancer]]></category>
		<category><![CDATA[HPV]]></category>
		<category><![CDATA[human papilloma virus]]></category>
		<category><![CDATA[National Comprehensive Cancer Network]]></category>
		<category><![CDATA[penile cancer]]></category>
		<category><![CDATA[screening]]></category>
		<category><![CDATA[tobacco]]></category>
		<category><![CDATA[vaccine]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=8099</guid>
		<description><![CDATA[
			
				
			
		
Source: www.businesswire.com
Author: press release
The Human Papillomavirus (HPV) is the causative agent responsible for most cases of cervical cancer, but is also associated with several other types of cancer. Expert physicians from the National Comprehensive Cancer Network (NCCN) Member Institutions presented an update on HPV and its link to various cancers including cervical cancer, anal carcinoma, [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/hpv-related-cancer-not-confined-to-cervix/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Oral Cancer Foundation donates screening devices to West Virginia Free Clinics</title>
		<link>http://oralcancernews.org/wp/oral-cancer-foundation-donates-screening-devices-to-west-virginia-free-clinics/</link>
		<comments>http://oralcancernews.org/wp/oral-cancer-foundation-donates-screening-devices-to-west-virginia-free-clinics/#comments</comments>
		<pubDate>Tue, 23 Feb 2010 19:46:22 +0000</pubDate>
		<dc:creator>Oral Cancer Foundation News Team</dc:creator>
				<category><![CDATA[OCF In The News]]></category>
		<category><![CDATA[Oral Cancer News]]></category>
		<category><![CDATA[alcohol]]></category>
		<category><![CDATA[Brian Hill]]></category>
		<category><![CDATA[chewing tobacco]]></category>
		<category><![CDATA[human papilloma virus]]></category>
		<category><![CDATA[oral cancer foundation]]></category>
		<category><![CDATA[oral lesions]]></category>
		<category><![CDATA[smokers]]></category>
		<category><![CDATA[spit tobacco]]></category>
		<category><![CDATA[tissue auto-fluorescence]]></category>
		<category><![CDATA[tobacco]]></category>
		<category><![CDATA[VELscope®]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=7951</guid>
		<description><![CDATA[
			
				
			
		
Source: www.prnewswire.com
Author: press release
In 2009 the Oral Cancer Foundation initiated a program of donating VELscope® Oral Cancer Screening Systems to free clinics.  The most recent recipients of this program are two West Virginia clinics: WV Health Right in Charleston, and the Susan Dew Hoff Memorial Clinic in West Milford.
&#8220;Our intent is to identify free [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/oral-cancer-foundation-donates-screening-devices-to-west-virginia-free-clinics/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Study suggests VELscope can help reduce recurrence of oral cancer</title>
		<link>http://oralcancernews.org/wp/study-suggests-velscope-can-help-reduce-recurrence-of-oral-cancer/</link>
		<comments>http://oralcancernews.org/wp/study-suggests-velscope-can-help-reduce-recurrence-of-oral-cancer/#comments</comments>
		<pubDate>Fri, 19 Feb 2010 05:37:36 +0000</pubDate>
		<dc:creator>Oral Cancer Foundation News Team</dc:creator>
				<category><![CDATA[Oral Cancer News]]></category>
		<category><![CDATA[HPV]]></category>
		<category><![CDATA[human papilloma virus]]></category>
		<category><![CDATA[lesions]]></category>
		<category><![CDATA[recurrence]]></category>
		<category><![CDATA[VELscope]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=7908</guid>
		<description><![CDATA[
			
				
			
		
Source: www.dentaleconomics.com
Author: staff
LED Dental has announced a recent study suggests that its VELscope screening system can help surgeons reduce the recurrence rate for oral cancer following surgery. The article, &#8220;Tracing the &#8216;At-Risk&#8217; Oral Mucosa Field with Autofluorescence: Steps Toward Clinical Impact,&#8221; was just published in the journal, Cancer Prevention Research. The article was was authored [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/study-suggests-velscope-can-help-reduce-recurrence-of-oral-cancer/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Oropharyngeal cancer, human papilloma virus, and clinical trials</title>
		<link>http://oralcancernews.org/wp/oropharyngeal-cancer-human-papilloma-virus-and-clinical-trials/</link>
		<comments>http://oralcancernews.org/wp/oropharyngeal-cancer-human-papilloma-virus-and-clinical-trials/#comments</comments>
		<pubDate>Wed, 30 Dec 2009 20:03:03 +0000</pubDate>
		<dc:creator>Oral Cancer Foundation News Team</dc:creator>
				<category><![CDATA[Oral Cancer News]]></category>
		<category><![CDATA[cetuximab]]></category>
		<category><![CDATA[cisplatin]]></category>
		<category><![CDATA[docetaxel]]></category>
		<category><![CDATA[fluorouracil]]></category>
		<category><![CDATA[HPV]]></category>
		<category><![CDATA[human papilloma virus]]></category>
		<category><![CDATA[molecular biology]]></category>
		<category><![CDATA[subtype]]></category>
		<category><![CDATA[survival]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=7678</guid>
		<description><![CDATA[
			
				
			
		
Source: Journal of Clinical Oncology, Vol 28, No 1 (January 1), 2010: pp. 1-3
Author: Danny Rischin
As advances in our understanding of the molecular biology of cancer have evolved in recent years, cancers that were once considered to be relatively homogeneous diseases are now being recognized as comprising distinct subtypes. These subtypes may differ in etiology, [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/oropharyngeal-cancer-human-papilloma-virus-and-clinical-trials/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Comparative prognostic value of HPV16 E6 mRNA compared with in situ hybridization for human oropharyngeal squamous carcinoma</title>
		<link>http://oralcancernews.org/wp/comparative-prognostic-value-of-hpv16-e6-mrna-compared-with-in-situ-hybridization-for-human-oropharyngeal-squamous-carcinoma-2/</link>
		<comments>http://oralcancernews.org/wp/comparative-prognostic-value-of-hpv16-e6-mrna-compared-with-in-situ-hybridization-for-human-oropharyngeal-squamous-carcinoma-2/#comments</comments>
		<pubDate>Sun, 20 Dec 2009 06:04:23 +0000</pubDate>
		<dc:creator>Oral Cancer Foundation News Team</dc:creator>
				<category><![CDATA[Oral Cancer News]]></category>
		<category><![CDATA[cohort]]></category>
		<category><![CDATA[disease-free survival]]></category>
		<category><![CDATA[HPV16]]></category>
		<category><![CDATA[human papilloma virus]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=7618</guid>
		<description><![CDATA[
			
				
			
		
Source: Journal of Clinical Oncology, Vol 27, No 36 (December 20), 2009: pp. 6213-6221
Authors: Wei Shi et al.
Purpose:
A significant proportion of oropharyngeal squamous cell carcinomas (OSCC) are associated with the human papilloma virus (HPV), particularly HPV16. The optimal method for HPV determination on archival materials however, remains unclear. We compared a quantitative real-time polymerase chain [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/comparative-prognostic-value-of-hpv16-e6-mrna-compared-with-in-situ-hybridization-for-human-oropharyngeal-squamous-carcinoma-2/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Should your son get the HPV vaccine?</title>
		<link>http://oralcancernews.org/wp/should-your-son-get-the-hpv-vaccine/</link>
		<comments>http://oralcancernews.org/wp/should-your-son-get-the-hpv-vaccine/#comments</comments>
		<pubDate>Sat, 28 Nov 2009 14:19:04 +0000</pubDate>
		<dc:creator>Oral Cancer Foundation News Team</dc:creator>
				<category><![CDATA[Oral Cancer News]]></category>
		<category><![CDATA[Gardasil]]></category>
		<category><![CDATA[HPV]]></category>
		<category><![CDATA[human papilloma virus]]></category>
		<category><![CDATA[vaccine]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=7434</guid>
		<description><![CDATA[
			
				
			
		
Source: www.nbc-2.com
Author: staff
TAMPA: David Hastings is back to helping his wife Jo at their Cuban restaurant outside Saint Petersburg. He&#8217;s grateful to be here after a very close call.
&#8220;One morning I was shaving and I noticed this side of my neck was swollen,&#8221; Hastings explained.
The diagnosis: stage four oral cancer. Until then, David was a [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/should-your-son-get-the-hpv-vaccine/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>After being diagnosed, Zenk Pinter is an oral cancer spokesperson</title>
		<link>http://oralcancernews.org/wp/after-being-diagnosed-zenk-pinter-is-an-oral-cancer-spokesperson/</link>
		<comments>http://oralcancernews.org/wp/after-being-diagnosed-zenk-pinter-is-an-oral-cancer-spokesperson/#comments</comments>
		<pubDate>Sat, 28 Nov 2009 14:11:44 +0000</pubDate>
		<dc:creator>Oral Cancer Foundation News Team</dc:creator>
				<category><![CDATA[OCF In The News]]></category>
		<category><![CDATA[Oral Cancer News]]></category>
		<category><![CDATA[Barbara Ryan]]></category>
		<category><![CDATA[Colleen Zenk Pinter]]></category>
		<category><![CDATA[Gardasil]]></category>
		<category><![CDATA[HPV]]></category>
		<category><![CDATA[human papilloma virus]]></category>
		<category><![CDATA[vaccine]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=7429</guid>
		<description><![CDATA[
			
				
			
		
Source: www.acorn-online.com
Author: Susan Wolf 
Colleen Zenk Pinter of Redding, an actor who stars as Barbara Ryan on As the World Turns, has partnered with the Oral Cancer Foundation, Yale New-Haven Hospital and Roswell Park Cancer Institute to be a spokesperson for oral cancer. Ms. Pinter was diagnosed with oral cancer in March 2007 and is [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/after-being-diagnosed-zenk-pinter-is-an-oral-cancer-spokesperson/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
